Saudi Arabia Blood Glucose Device Market to Reach US$ 259.8 Million by 2033, Growing at 6.78% CAGR

Saudi Arabia Blood Glucose Device Market Overview

The Saudi Arabia Blood Glucose Device Market is projected to grow from US$ 143.96 million in 2024 to US$ 259.8 million in 2033, expanding at a CAGR of 6.78% during 2025–2033. Growth is being driven by the country’s rising diabetes burden, technological advances in glucose monitoring, and proactive government initiatives that promote early diagnosis and self-management.

Advancements in Continuous Glucose Monitoring (CGM) systems, Bluetooth-enabled glucometers, and non-invasive sensors are improving patient compliance and outcomes. At the same time, health campaigns under Vision 2030 are pushing for early detection and prevention strategies, ensuring broader adoption across both urban and rural populations.

👉 Want to explore detailed market trends, segment insights, and forecasts? 🔗 Request Free Sample Report

Importance of Blood Glucose Monitoring

A blood glucose device is a medical tool that measures glucose levels in the blood, crucial for managing diabetes and preventing complications such as hypoglycemia, hyperglycemia, and long-term organ damage. Devices include:

Traditional glucometers with test strips

Continuous Glucose Monitors (CGMs) for real-time tracking

Flash glucose monitors, offering interval-based readings

In Saudi Arabia, demand for such devices is rising due to the alarming prevalence of Type 2 diabetes, fueled by sedentary lifestyles, high-calorie diets, and rising obesity levels. Accessibility through pharmacies, online platforms, and insurance support has further strengthened adoption.

Key Growth Drivers

1. Rising Type 2 Diabetes Prevalence

Saudi Arabia has one of the highest diabetes rates in the world. According to the IDF, around 4.27 million individuals currently live with diabetes, while another 1.86 million remain undiagnosed. Projections show this number could reach 7.5 million by 2045.

This growing health challenge is increasing demand for home monitoring devices. Regular glucose monitoring helps patients avoid complications, reduce hospital visits, and improve long-term disease management.

2. Technological Advancements

Modern glucose monitoring devices are revolutionizing diabetes management:

CGM systems offer real-time data

Bluetooth glucometers sync with smartphones

Wearables like Nemaura’s sugarBEAT, approved in 2023 by Saudi regulators, provide non-invasive glucose tracking

User-friendly designs, painless testing, and compact sizes make them attractive to younger and elderly patients alike. Global players entering the Saudi market are further expanding patient choice and driving adoption.

3. Government Support & Vision 2030 Initiatives

Healthcare reform under Vision 2030 emphasizes preventive care and chronic disease management. The Ministry of Health has launched campaigns for:

Early screening in schools and workplaces

Public awareness programs promoting self-monitoring

Insurance and subsidies to expand device affordability

In 2024, the Ministry of Health collaborated with Ithnain to provide innovative diabetes coaching for over 10,000 patients, aligning with Vision 2030 goals. Such initiatives are accelerating market penetration and device usage.

Market Challenges

High Cost of Advanced Devices

While CGMs and smart glucometers offer superior monitoring, their premium pricing remains a barrier. Limited insurance coverage makes these devices less accessible for low- and middle-income groups. As a result, many patients rely on older, less efficient devices.

Rural Awareness Gaps

Urban centers like Riyadh, Jeddah, and Dhahran benefit from strong healthcare infrastructure and awareness programs. However, rural regions still face limited knowledge, compliance issues, and weaker access to modern devices. Expanding outreach and distribution will be key for achieving widespread adoption.

👉 For deeper analysis, detailed segment data, and company insights: 🔗 Request Customization Report

Market Segmentation

By Product

Test Strips – Widely used due to affordability and convenience; recurring costs, however, pose challenges.

Lancets – Essential for blood collection, used with glucometers.

Blood Glucose Meters – Traditional and digital devices, with rising adoption of smart meters.

By Application

Type 1 Diabetes – Requires continuous monitoring.

Type 2 Diabetes – Largest segment due to high prevalence.

Gestational Diabetes – Growing awareness among pregnant women boosts demand.

By End User

Hospital Pharmacies – Provide devices during initial diagnosis; often subsidized.

Retail Pharmacies – Widely accessible, offering loyalty programs and home delivery.

Online Sales – Expanding with e-commerce and convenience-driven demand.

Diabetes Clinics & Centers – Focus on chronic management and patient education.

Regional Insights

Riyadh

As the capital and largest city, Riyadh dominates the market with its dense hospital network, diabetes centers, and early adoption of connected devices. Consumers prefer smart and app-based devices, reflecting the city’s tech-savvy population.

Jeddah

Jeddah has seen rising lifestyle disorders, fueling demand for both basic glucometers and advanced CGMs. The city’s mix of locals and expatriates contributes to diverse product adoption.

Dhahran

Home to affluent populations and strong private healthcare, Dhahran shows high adoption of advanced devices. Educational initiatives and hospital-led programs continue to support growth here.

Other Cities (Khobar, Dammam, etc.)

Secondary cities are gradually expanding access through retail chains like Al Nahdi, White Pharmacy, and Al-Dawaa, coupled with growing online sales.

Competitive Landscape

The Saudi Arabia blood glucose device market is moderately competitive, with both global leaders and local players active.

Key Players Include:

Abbott Laboratories

Medtronic

Dexcom Inc.

B. Braun Melsungen AG

DarioHealth Corp

Sanofi

Bionime Corporation

Novo Nordisk

These companies compete on innovation, distribution reach, and affordability. Partnerships with the Saudi Ministry of Health and local distributors are crucial for expanding market share.

Future Outlook

The Saudi Arabia Blood Glucose Device Market is poised for steady growth over the next decade. Key trends include:

Wider adoption of CGMs and wearables

Expansion of insurance coverage and subsidies

Growth of telemedicine and app-connected monitoring

Rising focus on rural outreach under Vision 2030

As diabetes cases rise, the need for accessible, affordable, and advanced glucose monitoring solutions will remain central to public health. By 2033, the market’s projected size of US$ 259.8 million reflects not only growing demand but also the success of national health strategies in tackling one of Saudi Arabia’s most pressing chronic diseases.

Note: If you need details, data, or insights not covered in this report, we are glad to assist. Through our customization service, we will collect and deliver the information you require, tailored to your specific needs. Share your requirements with us, and we will update the report to align with your expectations.